ID   RIOK2_HUMAN             Reviewed;         552 AA.
AC   Q9BVS4; D6RDI3; Q9NUT0;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   15-MAR-2017, entry version 141.
DE   RecName: Full=Serine/threonine-protein kinase RIO2;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:P40160};
DE   AltName: Full=RIO kinase 2;
GN   Name=RIOK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-349.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hepatoma;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TYR-144.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=16037817; DOI=10.1038/sj.emboj.7600752;
RA   Rouquette J., Choesmel V., Gleizes P.E.;
RT   "Nuclear export and cytoplasmic processing of precursors to the 40S
RT   ribosomal subunits in mammalian cells.";
RL   EMBO J. 24:2862-2872(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-390; SER-417 AND SER-442, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350; SER-380; SER-382;
RP   SER-385 AND SER-442, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, NUCLEAR EXPORT SIGNAL,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF LYS-123; ASP-246; LEU-400 AND
RP   ILE-403.
RX   PubMed=19564402; DOI=10.1083/jcb.200904048;
RA   Zemp I., Wild T., O'Donohue M.F., Wandrey F., Widmann B.,
RA   Gleizes P.E., Kutay U.;
RT   "Distinct cytoplasmic maturation steps of 40S ribosomal subunit
RT   precursors require hRio2.";
RL   J. Cell Biol. 185:1167-1180(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-362; SER-385; SER-390; SER-442 AND TYR-445, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-380; SER-382; SER-385 AND SER-390, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337
RP   AND SER-412, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-350; SER-380; SER-382; SER-390; SER-412 AND SER-442, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-96; ARG-144; HIS-155; ILE-175;
RP   THR-216; VAL-244; ARG-349; SER-397; ASP-409 AND HIS-507.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the final steps of cytoplasmic maturation of
CC       the 40S ribosomal subunit. Involved in export of the 40S pre-
CC       ribosome particles (pre-40S) from the nucleus to the cytoplasm.
CC       Its catalytic activity is required for the release of NOB1, PNO1
CC       and LTV1 from the late pre-40S and the processing of 18S-E pre-
CC       rRNA to the mature 18S rRNA. {ECO:0000269|PubMed:16037817,
CC       ECO:0000269|PubMed:19564402}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000250|UniProtKB:P40160}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305};
CC   -!- SUBUNIT: Associated with late 40S pre-ribosomal particles.
CC       {ECO:0000269|PubMed:16037817}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16037817,
CC       ECO:0000269|PubMed:19564402}. Note=Exported out of the nucleus via
CC       its NES in a XPO1-dependent manner. {ECO:0000269|PubMed:19564402}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BVS4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BVS4-2; Sequence=VSP_046388;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Autophosphorylated (in vitro). {ECO:0000269|PubMed:19564402}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. RIO-type
CC       Ser/Thr kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK002021; BAA92040.1; -; mRNA.
DR   EMBL; AK225348; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC008865; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000953; AAH00953.1; -; mRNA.
DR   CCDS; CCDS4089.1; -. [Q9BVS4-1]
DR   CCDS; CCDS54884.1; -. [Q9BVS4-2]
DR   RefSeq; NP_001153221.1; NM_001159749.1. [Q9BVS4-2]
DR   RefSeq; NP_060813.2; NM_018343.2. [Q9BVS4-1]
DR   UniGene; Hs.27021; -.
DR   PDB; 5DHF; X-ray; 2.29 A; D=389-403.
DR   PDBsum; 5DHF; -.
DR   ProteinModelPortal; Q9BVS4; -.
DR   SMR; Q9BVS4; -.
DR   BioGrid; 120896; 29.
DR   IntAct; Q9BVS4; 24.
DR   STRING; 9606.ENSP00000283109; -.
DR   BindingDB; Q9BVS4; -.
DR   ChEMBL; CHEMBL6000; -.
DR   GuidetoPHARMACOLOGY; 2187; -.
DR   iPTMnet; Q9BVS4; -.
DR   PhosphoSitePlus; Q9BVS4; -.
DR   BioMuta; RIOK2; -.
DR   DMDM; 143811448; -.
DR   EPD; Q9BVS4; -.
DR   MaxQB; Q9BVS4; -.
DR   PaxDb; Q9BVS4; -.
DR   PeptideAtlas; Q9BVS4; -.
DR   PRIDE; Q9BVS4; -.
DR   DNASU; 55781; -.
DR   Ensembl; ENST00000283109; ENSP00000283109; ENSG00000058729. [Q9BVS4-1]
DR   Ensembl; ENST00000508447; ENSP00000420932; ENSG00000058729. [Q9BVS4-2]
DR   GeneID; 55781; -.
DR   KEGG; hsa:55781; -.
DR   UCSC; uc003kmz.4; human. [Q9BVS4-1]
DR   CTD; 55781; -.
DR   DisGeNET; 55781; -.
DR   GeneCards; RIOK2; -.
DR   HGNC; HGNC:18999; RIOK2.
DR   HPA; HPA005681; -.
DR   neXtProt; NX_Q9BVS4; -.
DR   OpenTargets; ENSG00000058729; -.
DR   PharmGKB; PA134885533; -.
DR   eggNOG; KOG2268; Eukaryota.
DR   eggNOG; COG0478; LUCA.
DR   GeneTree; ENSGT00390000003255; -.
DR   HOGENOM; HOG000225685; -.
DR   HOVERGEN; HBG056045; -.
DR   InParanoid; Q9BVS4; -.
DR   KO; K07179; -.
DR   OMA; HRHNMSW; -.
DR   OrthoDB; EOG091G06ON; -.
DR   PhylomeDB; Q9BVS4; -.
DR   TreeFam; TF321400; -.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   GenomeRNAi; 55781; -.
DR   PRO; PR:Q9BVS4; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000058729; -.
DR   CleanEx; HS_RIOK2; -.
DR   ExpressionAtlas; Q9BVS4; baseline and differential.
DR   Genevisible; Q9BVS4; HS.
DR   GO; GO:0005737; C:cytoplasm; IMP:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0030688; C:preribosome, small subunit precursor; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030490; P:maturation of SSU-rRNA; IMP:UniProtKB.
DR   GO; GO:2000208; P:positive regulation of ribosomal small subunit export from nucleus; IMP:UniProtKB.
DR   GO; GO:2000234; P:positive regulation of rRNA processing; IDA:UniProtKB.
DR   GO; GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; TAS:Reactome.
DR   CDD; cd05144; RIO2_C; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR030484; Rio2.
DR   InterPro; IPR015285; RIO2_wHTH_N.
DR   InterPro; IPR000687; RIO_kinase.
DR   InterPro; IPR018935; RIO_kinase_CS.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF09202; Rio2_N; 1.
DR   SMART; SM00090; RIO; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01245; RIO1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ribosome biogenesis;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    552       Serine/threonine-protein kinase RIO2.
FT                                /FTId=PRO_0000213527.
FT   DOMAIN       97    272       Protein kinase. {ECO:0000305}.
FT   MOTIF       399    408       Nuclear export signal.
FT                                {ECO:0000269|PubMed:19564402}.
FT   ACT_SITE    228    228       Proton acceptor. {ECO:0000250}.
FT   BINDING     123    123       ATP. {ECO:0000250}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     335    335       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     337    337       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     380    380       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     382    382       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     385    385       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     390    390       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     412    412       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     417    417       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     442    442       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     445    445       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ     467    552       DEENVGAMNQYRTRTLSITSSGSAVSCSTIPPELVKQKVKR
FT                                QLTKQQKSAVRRRLQKGEANIFTKQRRENMQNIKSSLEAAS
FT                                FWGE -> YRLLSIAF (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_046388.
FT   VARIANT      96     96       S -> C (in dbSNP:rs2544773).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042347.
FT   VARIANT     144    144       H -> R (in dbSNP:rs35165987).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042348.
FT   VARIANT     144    144       H -> Y (in dbSNP:rs17849382).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031597.
FT   VARIANT     155    155       R -> H (in dbSNP:rs34916955).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042349.
FT   VARIANT     175    175       V -> I (in dbSNP:rs35713904).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042350.
FT   VARIANT     216    216       I -> T (in a renal clear cell carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs147608663).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042351.
FT   VARIANT     244    244       M -> V (in dbSNP:rs33996030).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042352.
FT   VARIANT     349    349       G -> R (in dbSNP:rs160632).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_031598.
FT   VARIANT     397    397       N -> S (in dbSNP:rs12188395).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_031599.
FT   VARIANT     409    409       E -> D (in dbSNP:rs35829000).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042353.
FT   VARIANT     507    507       R -> H (in dbSNP:rs34555783).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042354.
FT   MUTAGEN     123    123       K->A: Abolishes autophosphorylation;
FT                                impairs release of pre-40S trans-acting
FT                                factors and rRNA processing; when
FT                                associated with A-246.
FT                                {ECO:0000269|PubMed:19564402}.
FT   MUTAGEN     246    246       D->A: Abolishes autophosphorylation;
FT                                impairs release of pre-40S trans-acting
FT                                factors and rRNA processing; when
FT                                associated with A-123.
FT                                {ECO:0000269|PubMed:19564402}.
FT   MUTAGEN     400    400       L->A: Nuclear relocalization; when
FT                                associated with A-403.
FT                                {ECO:0000269|PubMed:19564402}.
FT   MUTAGEN     403    403       I->A: Nuclear relocalization; when
FT                                associated with A-400.
FT                                {ECO:0000269|PubMed:19564402}.
FT   HELIX       394    400       {ECO:0000244|PDB:5DHF}.
SQ   SEQUENCE   552 AA;  63283 MW;  6EB260E72DDB78D7 CRC64;
     MGKVNVAKLR YMSRDDFRVL TAVEMGMKNH EIVPGSLIAS IASLKHGGCN KVLRELVKHK
     LIAWERTKTV QGYRLTNAGY DYLALKTLSS RQVVESVGNQ MGVGKESDIY IVANEEGQQF
     ALKLHRLGRT SFRNLKNKRD YHKHRHNVSW LYLSRLSAMK EFAYMKALYE RKFPVPKPID
     YNRHAVVMEL INGYPLCQIH HVEDPASVYD EAMELIVKLA NHGLIHGDFN EFNLILDESD
     HITMIDFPQM VSTSHPNAEW YFDRDVKCIK DFFMKRFSYE SELFPTFKDI RREDTLDVEV
     SASGYTKEMQ ADDELLHPLG PDDKNIETKE GSEFSFSDGE VAEKAEVYGS ENESERNCLE
     ESEGCYCRSS GDPEQIKEDS LSEESADARS FEMTEFNQAL EEIKGQVVEN NSVTEFSEEK
     NRTENYNRQD GQRVQGGVPA GSDEYEDECP HLIALSSLNR EFRPFRDEEN VGAMNQYRTR
     TLSITSSGSA VSCSTIPPEL VKQKVKRQLT KQQKSAVRRR LQKGEANIFT KQRRENMQNI
     KSSLEAASFW GE
//
